It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
(visit the link for the full news article)
These media myths are repeated and create many misconceptions, which can be significant downside in the management of seasonal and pandemic influenza. They create an illusion of a near term universal vaccine that can lead to a single injection that will give long term protection against a wide range of influenza's, including various seasonal flu serotypes and pandemic influenza.
The requirement for high levels of monoclonal antibodies present serious practical considerations. Monoclonal antibodies for the treatment of various chronic conditions already exist and provide insight into the cost an utility of antibody treatment. Humira is approved for the treatment of rheumatoid arthritis. However, it is used at a dose of 40 mg/injection, or 1/25 of the level used in the mice experiments. Of greater concern however is the duration of a therapeutic dose in vivo. Monotherapy treatment with Humira requires weekly injections.
Originally posted by Grey Magic
I don't take flu shots, and I had the flu this year, a bad case of it.
But I guess I am the "what doesn't kill you only makes you stronger" type.